# ADNI (Alzheimer's Disease Neuroimaging Initiative)
> The Alzheimer's Disease Neuroimaging Initiative (ADNI) is a multisite longitudinal study designed to develop clinical, imaging, genetic, and biochemical biomarkers for the early detection and tracking of Alzheimer's disease. Launched in 2004, it operates as a public-private partnership, providing open-access data to researchers worldwide to accelerate the development of new treatments.
- URL: https://optimly.ai/brand/adni-alzheimer-s-disease-neuroimaging-initiative
- Slug: adni-alzheimer-s-disease-neuroimaging-initiative
- BAI Score: 88/100
- Archetype: Challenger
- Category: Research Initiative
- Last Analyzed: April 9, 2026
## Buyer Intent Signals
Problems: Manual Literature Review & Meta-Analysis: Researchers manually collate data from individual clinical trials or published literature without a centralized ecosystem. | Siloed Institutional Research: Conducting independent, isolated clinical longitudinal studies at a single institution.
Solutions: Alzheimer's disease longitudinal study data access | ADNI-4 recruitment goals | Public-private partnership for Alzheimer's research | Standardized biomarkers for AD progression | how to volunteer for brain imaging studies near me | UK Biobank: The UK Biobank provides large-scale genetic and health data, though not exclusively focused on AD progression markers like ADNI.